John Quisel
About John Quisel
John Quisel is the CEO with a robust background in law and biological sciences, known for his strategic roles in pharmaceutical collaborations.
John Quisel Chief Executive Officer
John Quisel currently serves as the Chief Executive Officer. With extensive experience in the pharmaceutical and legal sectors, he brings a wealth of knowledge to his leadership role. His background includes a tenure as Chief Business Officer at Acceleron Pharma, where he was integral in major licensing and collaboration agreements.
John Quisel Previous Roles
Before becoming CEO, John Quisel contributed significantly in legal and business capacities. He served as the Chief Business Officer at Acceleron Pharma. During his earlier career, he worked at prestigious law firms including Ropes & Gray and Foley Hoag. These roles equipped him with a robust understanding of legal and business strategies in the biotech industry.
John Quisel Education and Expertise
John Quisel has an impressive academic background. He received his undergraduate degree, summa cum laude, from Harvard College. He went on to earn an MSc from Stanford University and completed a PhD in Biological Sciences from MIT. Additionally, he holds a JD from Harvard Law School, demonstrating a strong foundation in both science and law.
John Quisel Key Contributions
John Quisel played a critical role in the in-licensing of sotatercept for pulmonary hypertension from Bristol-Myers Squibb. He also was instrumental in negotiating the collaboration agreement for the development and commercialization of luspatercept. These contributions highlight his impactful presence in the pharmaceutical industry.